Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N M Faber

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Nature|October 31, 2008
Doping: using flexible criteria could reduce false positivesN M Faber
Analytical and Bioanalytical Chemistry|April 10, 2002
Towards a rehabilitation of the generalized rank annihilation method (GRAM)N M Faber
Analytica Chimica Acta|July 4, 2007
How to avoid over-fitting in multivariate calibration--the conventional validation approach and an alternativeN M Faber, R Rajkó
Analytica Chimica Acta|May 12, 2009
IUPAC project: a glossary of concepts and terms in chemometricsD Brynn Hibbert, Pentti Minkkinen, N M Faber, et al.
Analytica Chimica Acta|March 28, 2007
Selecting the optimum number of partial least squares components for the calibration of attenuated total reflectance-mid-infrared spectra of undesigned kerosene samplesM P Gómez-Carracedo, J M Andrade, D N Rutledge, et al.
Lancet (London, England)|November 24, 1990
Typing of fetal platelet alloantigens when platelets are not availableR W Kuijpers, N M Faber, H H Kanhai, et al.
The Journal of Clinical Investigation|February 1, 1992
NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigensR W Kuijpers, N M Faber, H T Cuypers, et al.
Behaviour Research and Therapy|April 29, 2026
Effects of timing and type of trauma-focused treatment on psychosocial functioning: secondary outcomes from a randomized controlled trial in patients with co-occurring substance use disorder and posttraumatic stress disorderNathalie N M Faber, Sera Lortye, Arnoud Arntz, et al.
Alcohol, Clinical & Experimental Research|March 26, 2025
Trauma-related guilt, shame, and trauma type among patients with co-occurring PTSD and SUDNathalie N M Faber, Sera A Lortye, Loes A Marquenie, et al.
Blood|January 1, 1993
Single point mutation in human glycoprotein IIIa is associated with a new platelet-specific alloantigen (Mo) involved in neonatal alloimmune thrombocytopeniaR W Kuijpers, S Simsek, N M Faber, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Nature|October 31, 2008
Doping: using flexible criteria could reduce false positivesN M Faber
Analytical and Bioanalytical Chemistry|April 10, 2002
Towards a rehabilitation of the generalized rank annihilation method (GRAM)N M Faber
Analytica Chimica Acta|July 4, 2007
How to avoid over-fitting in multivariate calibration--the conventional validation approach and an alternativeN M Faber, R Rajkó
Analytica Chimica Acta|May 12, 2009
IUPAC project: a glossary of concepts and terms in chemometricsD Brynn Hibbert, Pentti Minkkinen, N M Faber, et al.
Analytica Chimica Acta|March 28, 2007
Selecting the optimum number of partial least squares components for the calibration of attenuated total reflectance-mid-infrared spectra of undesigned kerosene samplesM P Gómez-Carracedo, J M Andrade, D N Rutledge, et al.
Lancet (London, England)|November 24, 1990
Typing of fetal platelet alloantigens when platelets are not availableR W Kuijpers, N M Faber, H H Kanhai, et al.
The Journal of Clinical Investigation|February 1, 1992
NH2-terminal globular domain of human platelet glycoprotein Ib alpha has a methionine 145/threonine145 amino acid polymorphism, which is associated with the HPA-2 (Ko) alloantigensR W Kuijpers, N M Faber, H T Cuypers, et al.
Behaviour Research and Therapy|April 29, 2026
Effects of timing and type of trauma-focused treatment on psychosocial functioning: secondary outcomes from a randomized controlled trial in patients with co-occurring substance use disorder and posttraumatic stress disorderNathalie N M Faber, Sera Lortye, Arnoud Arntz, et al.
Alcohol, Clinical & Experimental Research|March 26, 2025
Trauma-related guilt, shame, and trauma type among patients with co-occurring PTSD and SUDNathalie N M Faber, Sera A Lortye, Loes A Marquenie, et al.
Blood|January 1, 1993
Single point mutation in human glycoprotein IIIa is associated with a new platelet-specific alloantigen (Mo) involved in neonatal alloimmune thrombocytopeniaR W Kuijpers, S Simsek, N M Faber, et al.
Pageof 2